BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 35981653)

  • 21. A three-dimensional collagen scaffold cell culture system for screening anti-glioma therapeutics.
    Lv D; Yu SC; Ping YF; Wu H; Zhao X; Zhang H; Cui Y; Chen B; Zhang X; Dai J; Bian XW; Yao XH
    Oncotarget; 2016 Aug; 7(35):56904-56914. PubMed ID: 27486877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Screening function enrichment and related signaling pathways bioinformatics analysis of differentially expressed gene in glioma].
    Chen YS; Guo Y; Shen HW; Zhang P; Chen H
    Zhonghua Yi Xue Za Zhi; 2019 Aug; 99(29):2311-2314. PubMed ID: 31434409
    [No Abstract]   [Full Text] [Related]  

  • 23. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 24. Tumor-associated macrophages based signaling pathway analysis and hub genes identification in glioma.
    Wang X; Ning W; Qiu Z; Li S; Zhang H; Yu C
    Medicine (Baltimore); 2020 Dec; 99(51):e23840. PubMed ID: 33371165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of crucial miRNAs and genes in esophageal squamous cell carcinoma by miRNA-mRNA integrated analysis.
    Zhong X; Huang G; Ma Q; Liao H; Liu C; Pu W; Xu L; Cai Y; Guo X
    Medicine (Baltimore); 2019 Jul; 98(27):e16269. PubMed ID: 31277149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Joint bioinformatics analysis of underlying potential functions of hsa-let-7b-5p and core genes in human glioma.
    Xi X; Chu Y; Liu N; Wang Q; Yin Z; Lu Y; Chen Y
    J Transl Med; 2019 Apr; 17(1):129. PubMed ID: 30995921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microarray data analysis to identify crucial genes regulated by CEBPB in human SNB19 glioma cells.
    Du C; Pan P; Jiang Y; Zhang Q; Bao J; Liu C
    World J Surg Oncol; 2016 Oct; 14(1):258. PubMed ID: 27716259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remodeling cancer stemness by collagen/fibronectin
    Zhong C; Tao B; Tang F; Yang X; Peng T; You J; Xia K; Xia X; Chen L; Peng L
    Theranostics; 2021; 11(4):1991-2005. PubMed ID: 33408794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening the Significant Hub Genes by Comparing Tumor Cells, Normoxic and Hypoxic Glioblastoma Stem-like Cell Lines Using Co-Expression Analysis in Glioblastoma.
    Güven E; Afzal M; Kazmi I
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In silico identification of key genes and signaling pathways targeted by a panel of signature microRNAs in prostate cancer.
    Baruah MM; Sharma N
    Med Oncol; 2019 Apr; 36(5):43. PubMed ID: 30937635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Candidate genes and microRNAs for glioma pathogenesis and prognosis based on gene expression profiles.
    Xie C; Xu M; Lu D; Zhang W; Wang L; Wang H; Li J; Ren F; Wang C
    Mol Med Rep; 2018 Sep; 18(3):2715-2723. PubMed ID: 30015885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
    Yu Y; Tian X
    Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Core Biomarkers Associated with Outcome in Glioma: Evidence from Bioinformatics Analysis.
    Geng RX; Li N; Xu Y; Liu JH; Yuan FE; Sun Q; Liu BH; Chen QX
    Dis Markers; 2018; 2018():3215958. PubMed ID: 30405856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of novel prognostic targets in glioblastoma using bioinformatics analysis.
    Yin X; Wu Q; Hao Z; Chen L
    Biomed Eng Online; 2022 Apr; 21(1):26. PubMed ID: 35436915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Ma J; Gui H; Tang Y; Ding Y; Qian G; Yang M; Wang M; Song X; Lv H
    Front Genet; 2021; 12():585058. PubMed ID: 33868359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of gene profiles in glioma cells identifies potential genes, miRNAs, and target sites of migratory cells.
    Xue F; Shen R; Chen X
    Tumori; 2015; 101(5):542-8. PubMed ID: 25953448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.